Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes
- PMID: 26180890
- Bookshelf ID: NBK305021
Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes
Excerpt
Striving towards a person-centred service through joint working across health and social care and cross-sector working (for example with commercial organisations) achieves the best possible outcomes for the person. This incorporates a patient's values and preferences and minimises harm, supporting effective medicines optimisation. This guideline reviews the evidence available to support health and social care practitioners, and health and social care organisations, in considering the systems and processes required to ensure safe and effective medicines optimisation.
In this guideline, the term ‘medicines’ covers all healthcare treatments, such as oral medicines, topical medicines, inhaled products, injections, wound care products, appliances and vaccines. The guideline will assume that prescribers will use a medicine's summary of product characteristics to inform decisions made with individual patients.
Copyright © National Institute for Health and Care Excellence,
Sections
- Guideline development group members
- Acknowledgements
- 1. Introduction
- 2. Development of a NICE clinical guideline
- 3. Methods
- 4. Guideline summary
- 5. Systems for identifying, reporting and learning from medicines-related patient safety incidents
- 6. Medicines-related communication systems when patients move from one care setting to another
- 7. Medicines reconciliation
- 8. Medication review
- 9. Self-management plans
- 10. Patient decision aids used in consultations involving medicines
- 11. Clinical decision support
- Medicines-related models of organisational and cross-sector working
- 13. Reference list
- 14. Glossary
- Appendices
Publication types
LinkOut - more resources
Full Text Sources
Medical